$VTIX

Year After Meta Launch – Minichart

Virtuix (VTIX) reported Q1 fiscal 2027 results, with Omni One orders up 72% YoY and 150% since Meta launch. Revenue fell 26% to $0.8M, but gross profit rose 29% to $227K. Net loss widened to $7.2M due to non-cash charges. The company advanced defense projects and sold to Tesla. Cash decreased to $7.4M, with increased operating expenses.

Original reporting
Published Aug 20, 2026, 10:48 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 12:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Year After Meta Launch – Minichart — source image
Decision brief

The 30-second read

$VTIXNeutralMed
01

Why it matters

The earnings release provides the first detailed financial snapshot for FY2027, introducing new data on order growth and defense contracts.

02

Market read

Micro‑cap earnings with notable order growth but widening losses; relevant for traders tracking niche VR/defense tech stocks.

03

What to watch

Potential future contracts with Tesla and NASA could provide longer‑term revenue streams.

Relevance 6/10Novelty 6/10Timing: post‑earnings release

Background

Virtuix is a small publicly traded VR hardware company focusing on training simulators.

Company-level read

Ticker impact

$VTIXNeutralMedium confidence
Context

Virtuix Holdings reported Q1 FY2027 results with a 72% YoY order surge and a net loss narrowing, providing fresh earnings data.

Expected impact

Potential modest upside if market focuses on order acceleration; downside risk from widening net loss.

Evidence & confidence

Order growth signals demand, but higher expenses and widening loss may limit upside.

Market effects

Highlights growing demand for VR training solutions in defense and enterprise sectors.

May boost interest in U.S. defense‑tech microcaps.

Limited to niche VR/AR and defense training markets.

Counterpoint

Order surge may be temporary; cash burn and widening loss could outweigh short‑term optimism.

Key entities

  • Virtuix Holdings Inc.

    NASDAQ‑listed VR training hardware provider.

  • Meta

    Platform partner for the Omni One product launch.

Related articles

$VTIXMed

Research firm sees 644% potential upside for Virtuix; orders rose 72% after Meta partnership

Emerging Growth Research reaffirmed its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), implying 644% upside. Q1 2027 revenue was $0.8M, down 26% YoY but above estimates, driven by a 72% rise in new orders post-Meta partnership. Gross margin expanded to 30%, and EPS improved sequentially to $(0.22). The firm projects 19% and 275% revenue growth for fiscal 2027 and 2028, respectively, but notes execution and financing risks.

$VTIXMed

Virtuix Holdings Inc. (VTIX): Results of Operations and Financial Condition

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand Gross Pr

$VTIXHigh

Virtuix Q1 sales $767K, EPS ($0.22) beat estimates

Virtuix (VTIX) reported Q1 FY2027 net sales of $767K, beating estimates, with a net loss per share of ($0.22). Gross profit rose 29% to $227K, driven by higher selling prices. Operating expenses increased 86% to $4.1M. The company secured its first Omni One Enterprise sale to Tesla. Cash reserves stood at $7.4M. The earnings release and conference call were rescheduled to August 19-20, 2026, due to a new audit firm's review.

$VTIXMed

Virtuix Reports 72% Year-over-Year Order Growth, Margin Expansion, and New Defense, Enterprise, and Healthcare Wins in Fiscal Q1 2027

Virtuix reported a 72% year-over-year increase in orders and a 29% rise in gross profit for Q1 2027. Gross margin expanded to 30% from 17%. The company secured new defense, enterprise, and healthcare contracts, including deals with Tesla, NASA, and the U.S. Marine Corps. Net sales were $0.8 million, down 26% year-over-year, but orders surged.